Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria-Reference-Cited by-同舟云学术

Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria

Published:2019-12 Issue:12 Volume:21 Page:1697-1706
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Ludwig Daniel R.,Fraum Tyler J.,Cannella Roberto,Tsai Richard,Naeem Muhammad,LeBlanc Maverick,Salter Amber,Tsung Allan,Fleckenstein Jaquelyn,Shetty Anup S.,Borhani Amir A.,Furlan Alessandro,Fowler Kathryn J.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. Hepatocellular carcinoma (HCC): a global perspective;Ferenci;J Clin Gastroenterol,2010

2. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

3. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis;Tang;Abdom Radiol (NY),2018

4. 2014 Korean liver cancer study group-national cancer center Korea practice guideline for the management of hepatocellular carcinoma;Korean J Radiol,2015

5. Diagnosis, staging and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases;Marrero;Hepatology,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma;APMIS;2023-04-25

2. Application of biological big data and radiomics in hepatocellular carcinoma;iLIVER;2023-03

3. Adherence to LI-RADS and EASL high-risk population criteria: A systematic review;Hepatology;2023-02-23

4. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice;Proteomes;2023-01-10

5. Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2022-09-30